A new report on medicines and their use in the U.S. indicates that spending on medicines fell in 2016 as competition intensified, with spending only growing 4.8 percent in 2016 and brand-name medicine prices only increasing 3.5 percent after accounting for negotiated discounts and rebates. The report also found that more than half of commercial patients’ out-of-pocket spending for brand medicines were filled in the deductible or with coinsurance, meaning patients paid the full list price for their medicines, even if their insurer received a discount. Read more on the report here.
Last Updated on May 13, 2020 by Aimed Alliance
